GH1 and Duchenne muscular dystrophy: The enhancement of growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis by the direct use of GH or IGF-1 has been proposed in DMD to improve muscle anabolism and myogenic program and for reducing the deleterious effects of glucocorticoids on patients’ growth (4, 19).